Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Terns Pharmaceuticals Inc (TERN)

Terns Pharmaceuticals Inc (TERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
This Small-Cap Biotech Could Gain Over 165%, Says Wall Street

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing drugs to combat obesity. Is TERN stock a good buy right now?

TERN : 5.56 (-5.12%)
VKTX : 73.64 (-8.18%)
LLY : 760.00 (-1.50%)
NVO : 128.42 (-0.19%)
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?

Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while.

GALT : 3.03 (-6.77%)
GLMD : 0.3983 (-4.02%)
VKTX : 73.64 (-8.18%)
ETNB : 8.71 (-4.39%)
IVA : 3.38 (-1.46%)
SGMT : 4.44 (-2.84%)
TERN : 5.56 (-5.12%)
NVO : 128.42 (-0.19%)
IQV : 234.08 (+2.13%)
MDGL : 205.25 (-0.81%)
3 Biotechs Compete for the Same $108-Billion-Dollar Market. Are They a Buy?

NASH treatments are projected to be one of the most sought-after indications in the coming years.

MDGL : 205.25 (-0.81%)
TERN : 5.56 (-5.12%)
VKTX : 73.64 (-8.18%)
Looking for the Next Big Biopharma Stock? These 4 Letters Are 1 Big Clue Where to Find It

NASH is a surprisingly common ailment, and the first treatments are on the way.

GILD : 65.96 (+2.14%)
NVO : 128.42 (-0.19%)
LLY : 760.00 (-1.50%)
TERN : 5.56 (-5.12%)
VKTX : 73.64 (-8.18%)
MDGL : 205.25 (-0.81%)
Terns Pharmaceuticals, Inc. (TERN) Is Up 15.12% in One Week: What You Should Know

Does Terns Pharmaceuticals, Inc. (TERN) have what it takes to be a top stock pick for momentum investors? Let's find out.

TERN : 5.56 (-5.12%)
Why Shares of Terns Pharmaceuticals Soared This Week

The company is showing progress toward a NASH therapy.

NVS : 102.10 (+1.89%)
TERN : 5.56 (-5.12%)
Take the Zacks Approach to Beat the Market: Uber, Baidu, AssetMark in Focus

Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.

ITW : 250.33 (+0.24%)
HSY : 204.78 (+2.34%)
BIDU : 108.66 (-1.99%)
CLX : 143.35 (+1.26%)
INTU : 632.31 (+0.87%)
AXON : 303.43 (-1.83%)
NOBL : 99.77 (+0.32%)
UBER : 66.99 (-1.38%)
AMK : 33.87 (-0.03%)
TERN : 5.56 (-5.12%)
VTYX : 4.09 (-8.71%)
Are You Looking for a Top Momentum Pick? Why Terns Pharmaceuticals, Inc. (TERN) is a Great Choice

Does Terns Pharmaceuticals, Inc. (TERN) have what it takes to be a top stock pick for momentum investors? Let's find out.

TERN : 5.56 (-5.12%)
Pre-Market Brief: Stocks Mostly Lower as Economic Outlook Darkens, BoJ Policy Shift

March S&P 500 futures (ESH23) are trending down -0.08% this morning after three major U.S. benchmark indices closed lower for a fourth straight session, with Nasdaq dropping the most as market participants'...

ESH23 : 3,957.05s (-0.09%)
META : 476.20 (+0.16%)
ICCM : 1.1400 (-2.56%)
LCID : 2.66 (-1.48%)
SLNO : 44.99 (-5.56%)
TERN : 5.56 (-5.12%)
SMCI : 798.50 (-0.15%)
Zacks.com featured highlights include Terns Pharmaceuticals, AllianceBernstein Holding and ALLETE

Terns Pharmaceuticals, AllianceBernstein Holding and ALLETE have been highlighted in this Screen of The Week article.

AB : 32.58 (-1.30%)
ALE : 63.20 (+0.43%)
TERN : 5.56 (-5.12%)

Barchart Exclusives

3 Dividend Kings That Cut (Or Will Cut) Their Dividends
Dividend aristocracy isn't always a sure thing. Here are 3 companies that have been or will be booted from the coveted king's list. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar